[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@OncNewsCentral](/creator/twitter/OncNewsCentral)
"A timely read for oncology professionals: GLP-1 drugs are everywhere but what do they mean for cancer care #Oncology #CancerCare #GLP1"  
[X Link](https://x.com/OncNewsCentral/status/1978122906518396961) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-14T15:37Z 1998 followers, XX engagements


"Radiopharmaceutical therapy for prostate cancer is a hot topic now says @UCLAHealth's @CalaisJeremie. He spoke with @OncNewsCentral about which findings at #ESMO25 (@myESMO) are most anticipated: #ProstateCancer"  
[X Link](https://x.com/OncNewsCentral/status/1979151934444445914) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-17T11:46Z 1998 followers, XX engagements


"Starting salaries for oncologists have hit $490K in 2025 up nearly $90K since 2021. Oncology now ranks as the most in-demand specialty according to @AMNHealthcare. 🔗"  
[X Link](https://x.com/OncNewsCentral/status/1979188944827740294) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-17T14:13Z 1997 followers, XX engagements


"Whats next after T-DXd in metastatic breast cancer Real-world data published in @JNCI_Now show limited durability with follow-up therapies and wide variation by subtype. 🔗 #BreastCancer"  
[X Link](https://x.com/OncNewsCentral/status/1979191693472665966) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-17T14:24Z 1998 followers, XX engagements